{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-202195","form_type":"8-K","ticker":"LBRX","cik":"0001691082","company_name":"LB PHARMACEUTICALS INC","filed_at":"2025-09-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.676780+00:00","generated_at":"2026-05-17T06:45:03.655456+00:00","sec_items":["5.03","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"LB Pharmaceuticals adopts amended charter and bylaws upon IPO closing on Sept 12, 2025","bullets":["Filed amended and restated certificate of incorporation with Delaware Secretary of State.","Adopted amended and restated bylaws effective immediately prior to IPO closing.","Both documents previously approved by board and stockholders.","IPO closed on September 12, 2025; common stock trades on Nasdaq under LBRX."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-202195","json":"https://secwatch.observer/filing/0001193125-25-202195.json","markdown":"https://secwatch.observer/filing/0001193125-25-202195.md","text":"https://secwatch.observer/filing/0001193125-25-202195.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1691082/000119312525202195/0001193125-25-202195-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1691082/000119312525202195/d32696d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T06:45:03.655456+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5cb5de6b610fa098a034652eea43268278229c98","claim":"LB PHARMACEUTICALS INC: Filed amended and restated certificate of incorporation effective upon closing of IPO (effective 2025-09-12).","evidence_excerpt":"the Company filed an amended and restated certificate of incorporation (the “ Restated Certificate ”) with the Secretary of State of the State of Delaware","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1691082/000119312525202195/0001193125-25-202195-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2025-09-12"}],"fact_type":"governance_change"},{"claim_id":"84ee5c9276e6a4ffc25bcc359b2d636f980d648c","claim":"LB PHARMACEUTICALS INC: Adopted amended and restated bylaws effective upon closing of IPO (effective 2025-09-12).","evidence_excerpt":"Effective as of September 12, 2025, the Company adopted amended and restated bylaws (the “ Restated Bylaws ”) in connection with the closing of the IPO","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1691082/000119312525202195/0001193125-25-202195-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"bylaw amendment"},{"label":"Effective","value":"2025-09-12"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}